Novartis reported $117.45B in Assets for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Amgen AMGN:US USD 65.12B 1.42B
AstraZeneca AZN:LN USD 94.18B 2.39B
Astrazeneca AZN:US USD 94.18B 2.39B
Biogen BIIB:US USD 24.85B 227.2M
Canopy Growth Corp WEED:CN CAD 3.4B 115.26M
Catalent CTLT:US USD 10.2B 302M
Corcept Therapeutics CORT:US USD 533.26M 36.89M
Drreddys Laboratories RDY:US INR 309.3B 18.33B
Endo International Ordinary Shares ENDP:US USD 6.01B 355.8M
Gilead Sciences GILD:US USD 63.17B 614M
GlaxoSmithKline GSK:LN GBP 60.15B 167M
Glaxosmithkline GSK:US GBP 60.15B 167M
Horizon Pharma HZNP:US USD 9.03B 174.39M
JAZZ PHA JAZZ:US USD 10.38B 815.47M
Lannett LCI:US USD 438.36M 28.94M
Novartis NOVN:VX USD 118.46B 4.45B
Pacira Pharmaceuticals PCRX:US USD 1.73B 377K
Perrigo Ordinary Shares PRGO:US USD 10.68B 242.1M
Phibro Animal Health PAHC:US USD 948.38M 16.68M
Prestige Brands PBH:US USD 3.75B 71.26M
Roche Holding ROG:VX 86.74B 5.58B
Supernus Pharmaceuticals SUPN:US USD 1.69B 1.84M
Teva Pharmaceutical Industries TEVA:US USD 44.25B 1.68B
Valeant Pharmaceuticals VRX:CN USD 26.3B 1.87B
Zoetis ZTS:US USD 13.67B 96M